INTRODUCTION
============

Vascular endothelial cells (ECs) form the inner lining of blood vessel wall, are directly exposed to blood flow, and serve important homeostatic functions in response to various chemical and mechanical stimuli ([@b5-molcell-37-6-435]; [@b14-molcell-37-6-435]; [@b27-molcell-37-6-435]; [@b28-molcell-37-6-435]; [@b29-molcell-37-6-435]; [@b38-molcell-37-6-435]; [@b46-molcell-37-6-435]). In addition, ECs modulate a variety of biologic processes within the vessel wall, including active regulation of vascular tone and blood pressure through nitric oxide, endothelin, and angiotensin II ([@b4-molcell-37-6-435]), suppression of inappropriate activation of the coagulation system through the production of antithrombotic factors ([@b47-molcell-37-6-435]), and regulation of cell proliferation and angiogenesis through secretion of various growth factors and vasoactive substances ([@b39-molcell-37-6-435]), indicating that ECs in general poses athero-protective functions.

Steady laminar flow (10--20 dyn/cm^2^) promotes release of factors from ECs that inhibit coagulation, leukocyte diapedesis, and smooth muscle cell proliferation while simultaneously promoting EC survival ([@b20-molcell-37-6-435]; [@b45-molcell-37-6-435]). These data suggest that steady laminar flow maintains ECs functional and athero-protective. In contrast, dysfunctional (athero-prone) ECs are readily observed in certain areas of the arterial tree, where disturbed flow, hence reduced time-averaged shear stress, develops ([@b48-molcell-37-6-435]; [@b52-molcell-37-6-435]). ECs in these regions have an activated, pro-inflammatory phenotype that is characterized by poor alignment, high turnover, and being under oxidative stress ([@b2-molcell-37-6-435]). Furthermore, substantial evidence supports that disturbed flow alters the profile of secreted factors and EC surface molecule expression to that favoring the development of atherosclerosis ([@b28-molcell-37-6-435]; [@b29-molcell-37-6-435]; [@b48-molcell-37-6-435]), thrombosis ([@b36-molcell-37-6-435]), and EC dysfunction ([@b37-molcell-37-6-435]), supporting that disturbed flow is athero-prone. Again, accumulating evidence suggest that steady laminar flow and disturbed flow have different effects in regulating EC function and subsequent atherosclerotic plaque formation, but lack of knowledge on the molecular mechanisms to define these two different flows effects has hindered our capability of developing anti-atheosclerotic therapy by modulating EC function. Therefore, understanding how various signal transduction pathways are affected by disturbed blood flow to cause EC dysfunction and subsequent cardiovascular diseases is critically important. This review will also highlight the emerging evidence that shear stress induced signaling in ECs is the critical early step in many cardiovascular diseases.

*IN VIVO* AND *IN VITRO* MODELS FOR BLOOD FLOW STUDIES
======================================================

ECs of large arteries *in vivo* are constantly exposed to hemodynamic forces, such as shear stress and cyclic strain, of flowing blood. Typically, in the straight portions of a blood vessel, the flow is laminar. In these regions, ECs align and elongate parallel to the direction of flow. This alignment is thought to reduce resistance to flow and to activate signaling cascades that protect ECs from becoming dysfunctional. In contrast, blood flow within acute vessel curvatures, branch points, and bifurcations is typically disturbed, exhibiting flow reversal, separation, and overall low shear stress. As a result, ECs do not align parallel to the vessel long axis and show a less polarized shape, so-called cobblestone morphology. Because the cells do not align with the general direction of flow, their topology exposes them to greater shear stress gradients across the length of the cell, and these areas are also more prone to atherosclerosis ([@b27-molcell-37-6-435]). For instance, within the carotid bifurcation, where atherosclerosis often develops, the flow separates, disrupting the laminar profile and producing disturbed streamlines ([@b14-molcell-37-6-435]; [@b27-molcell-37-6-435]; [@b40-molcell-37-6-435]). To examine the mechanosignaling events caused by blood flow separately from those induced by chemical humoral effectors, *in vitro* mechanical devices have been designed to apply different types of fluid flow over a lawn of cultured ECs. To study effects of different flow patterns on ECs *in vivo*, different regions of the aorta are targeted for analysis. Here, we will briefly introduce *En face* immunochemistry used to study flow-induced mechanotransduction in ECs *in vivo.*

EN FACE IMMUNOHISTOCHEMISTRY
============================

The specific areas exposed to laminar flow and disturbed flow within the aorta can be identified based on the published and generally accepted anatomical locations where such flow patterns are known to occur ([@b24-molcell-37-6-435]; [@b30-molcell-37-6-435]; [@b34-molcell-37-6-435]). For example, a typical laminar flow area is located in the greater curvature area and is marked as a low probability region for lesion formation ([@b24-molcell-37-6-435]), which is also known as a high wall shear stress area. A disturbed flow area is the lesser curvature area where lesion formation is more prevalent ([@b24-molcell-37-6-435]; [@b30-molcell-37-6-435]; [@b34-molcell-37-6-435]) and is also indicated as a low wall shear stress area. EC shape outlined by anti-VE-cadherin staining can be also used to identify laminar flow areas (elongated cell shape) and disturbed flow areas (irregular cell shape) ([Fig. 1](#f1-molcell-37-6-435){ref-type="fig"}).

Mouse aorta *en face* preparations are made in the following manner. Mice are euthanized by CO~2~ inhalation, and aorta is exposed by opening the abdominal cavity followed by cutting the ribs laterally to the sternum to open thoracic cavity. The arterial tree is perfused *via* the left ventricle with saline containing heparin (40 USPU/ml) with a 26.5-gauge needle attached to a gravity perfusion set up (pressure by height: around 100 cm hydrostatic pressure) to flush out blood, followed by perfusion with 4% paraformaldehyde in PBS for 10 min. The aorta is dissected out using blunt curved scissors and forceps from the heart all the way to the iliac bifurcation including 3--5 mm of iliac arteries. It is important not to pull on the aorta as stretching damages the endothelium. After adipose tissues are removed, aortas are cut open longitudinally and permeabilized with PBS containing 0.1% Triton X-100 and blocked by Protein Block Serum (DAKO, X0909) for 30 min, followed by indirect immunofluorescence staining. To obtain images shown in [Fig. 1](#f1-molcell-37-6-435){ref-type="fig"}, the aorta was incubated with rat anti-VE-cadherin (endothelial cell marker) in the antibody diluent solution (DAKO, S0809) overnight. After a PBS rinse, anti-rat IgG (Alexa Fluor 488, Molecular Probes) were applied for 1 h at room temperature. Images were acquired using a confocal laser-scanning microscope equipped with krypton/argon/HeNe laser lines.

MECHANOSENSORS OF ENDOTHELIAL SHEAR STRESS
==========================================

Elucidating the primary mechano-sensor that enables vascular ECs to distinguish between different flow profiles has been a major challenge in the field, although possible mechano-sensing macromolecules and a variety of sensor cell structures have been proposed ([@b33-molcell-37-6-435]) including endothelial cell-cell junction ([@b9-molcell-37-6-435]; [@b49-molcell-37-6-435]), heterotrimeric G-proteins ([@b23-molcell-37-6-435]), caveolae ([@b58-molcell-37-6-435]), focal adhesions and integrins ([@b31-molcell-37-6-435]), primary cilium ([@b41-molcell-37-6-435]), glycocalyx ([@b13-molcell-37-6-435]), intermediate filaments ([@b26-molcell-37-6-435]), ion channels ([@b3-molcell-37-6-435]), and the actin cytoskeleton ([@b43-molcell-37-6-435]).

Davies et al. have suggested that the focal adhesion undergoes rapid remodeling in response to flow ([@b14-molcell-37-6-435]; [@b15-molcell-37-6-435]). In addition, fluid shear stress generated by blood flow increased accumulation of phosphotyrosin-containing protein and Src protein at the lateral cell border of endothelium, suggesting the various signaling events at the site of cell-cell junction ([@b35-molcell-37-6-435]). Our group reported that laminar flow induced a rapid tyrosine phosphorylation of 128 kDa glycoprotein in ECs, and identified it as platelet endothelial cell adhesion molecule (PECAM-1) ([@b42-molcell-37-6-435]). PECAM-1 belongs to the immunoglobulin-inhibitory receptor family, which is characterized by six extracellular immunoglobulin-like domains, and also contains one trans-membrane domain and a short cytoplasmic domain. Within its short cytoplasmic domain two immunoreceptor tyrosine-based inhibitory motifs (ITIMs) exist, which are believed to have crucial role in initiating PECAM1-1-mediated mechano-transduction. Arguably, PECAM-1 is one of the rigorously characterized EC mechanotransducer with clear implications to cardiovascular diseases.

The crucial role of PECAM-1 as a primary "mechano-sensor" has been proposed based on the following studies by our group. First, any secondary events in signaling pathways including phosphoinositide turnover, increased cytoplasmic Ca^2+^, or PKC activation did not induce PECAM-1 tyrosine phosphorylation, suggesting the direct effect of mechanical force in induction of PECAM-1 tyrosine phosphorylation ([@b42-molcell-37-6-435]). Second, in order to directly apply mechanical force to PECAM-1 we generated magnetic beads coated with antibodies against the PECAM-1 external domain to capture PECAM-1 on the cell surface, and then pulled the PECAM-1 eternal domain directly by applying magnetic force. We found that the only fraction of PECAM-1 bound to beads was phosphorylated and subsequently recruited SHP2 and activated ERK1/2 after magnetic force was applied ([@b42-molcell-37-6-435]). Taken together these data strongly suggest that PECAM-1 is a "mechanosensor" and PECAM-1 tyrosine phosphorylation and recruitment of SHP-2 to its tyrosine phosphorylation site are the initiating processes of this mechano-transduction system. The next question is how PECAM-1 tyrosine phosphorylation is initiated, because PECAM-1 contains no intrinsic enzyme activity. Our group found that Fyn is responsible to shear stress-induced PECAM-1 tyrosine phosphorylation ([@b11-molcell-37-6-435]). Based on these data we propose the following mechanism for the role of PECAM-1 in regulating shear stress-induced signaling. In the absence of shear stress, the ITIMs are covered by itself or other unidentified proteins, thus protecting them from phosphorylation. Once shear stress is applied, this protective mechanism is removed and Y713 (one of the ITIMs) is phosphorylated by Fyn, leading to SHP-2 binding and subsequently increase ERK1/2 activation ([@b42-molcell-37-6-435]). Of note we could not detect Fyn kinase activation induced by shear stress, we believe that Fyn-mediated PECAM-1 phosphorylation is due to either a conformational change in the PECAM-1 cytoplasmic tail ([@b11-molcell-37-6-435]) or the removal of protective mechanism from phosphorylation, but the detailed mechanism of this removing process remains largely unclear.

Subsequently, Schwarts' group has proposed that a complex of vascular endothelial cell cadherin (VE-cadherin), PECAM-1, and vascular endothelial growth factor receptor 2 (VEGFR2) at cell-cell junctions form a mechanotransduction complex ([@b12-molcell-37-6-435]). In this study, they examined whether PECAM-1, VE-cadherin, and VEGFR2 are sufficient to transduce shear stress by transfection of encoding plasmids to COS-7 African green monkey cells and found that cells co-expressing all three proteins activated AKT and aligned in the direction of flow. Interestingly, none of the single- or double-transfected cells showed any response to flow, suggesting that PECAM-1, VE-cadherin, and VEGFR2 represent the essential EC-specific components needed for the alignment of cells by shear stress. In addition, these proteins mainly induced flow-mediated inflammatory events *via* activation of NF-κB, suggesting the crucial role of PECAM-1/VE-cadherin/VEGFR2 signaling under athero-prone flow ([@b50-molcell-37-6-435]). However, the role of PECAM-1 in regulating atherosclerotic plaque formation is not that simple. Based on the studies by Goel et al. ([@b22-molcell-37-6-435]) and Harry et al. ([@b25-molcell-37-6-435]), PECAM-1 promotes plaque formation in the lesser curvature of the aortic arch, which is exposed to disturbed (athero-prone) flow. In contrast, the plaque formation was increased in laminar (athero-protective) flow area in the PECAM-1 deficient mice ([@b22-molcell-37-6-435]). These data suggest that PECAM-1 can be a mechanosensor for both athero-prone and athero-protective flow. We propose that different modulating elements work with PECAM-1 under steady laminar and disturbed flow, generating different overall cellular responses in ECs under these two flow patterns. Further investigations are necessary to clarify this issue.

ATHEROSCLEROSIS AND FLOW SIGNALING
==================================

Many of the anti-atherosclerotic signals are activated by steady laminar flow, which down-regulates a number of inflammatory genes in ECs as documented by numerous transcriptional profiling studies ([@b6-molcell-37-6-435]; [@b16-molcell-37-6-435]; [@b17-molcell-37-6-435]; [@b19-molcell-37-6-435]; [@b44-molcell-37-6-435]; [@b55-molcell-37-6-435]). Roles of Gab1 and SHP2 in the shear stress-induced phosphorylation and activation of Akt and eNOS in cultured and in situ endothelial cells have been suggested ([@b18-molcell-37-6-435]). Laminar shear stress-induced phosphorylation of eNOS on Ser1177 was attributed not only to the activation of the Ca^2+^/calmodulin-dependent kinase II in bradykinin-stimulated endothelial cells but also to Akt activation in cells stimulated with vascular endothelial growth factor or hepatocyte growth factor (HGF) and protein kinase A (PKA) ([@b16-molcell-37-6-435]).

As explained above, endothelial dysfunction caused by disturbed flow is thought to be one of the primary culprits in the progression of atherosclerosis ([@b28-molcell-37-6-435]). Besides PECAM-1/VE-cadherin/VEGFR2 signaling, we found a crucial role of SUMOylation in regulating endothelial dysfunction and atherosclerotic plaque formation under disturbed flow. SUMOylation is a unique post-translational modification akin to ubiquitination, that conjugates small ubiquitin-like proteins called small ubiquitin-like modifier (SUMO) to target proteins and affects a number of processes including the localization, degradation, binding, and activity of SUMOylated proteins ([@b21-molcell-37-6-435]). SUMOylation plays an important role in regulating variety of endothelial function including actin filament remodeling ([@b7-molcell-37-6-435]), migration ([@b7-molcell-37-6-435]), inflammation ([@b54-molcell-37-6-435]), and apoptosis ([@b28-molcell-37-6-435]).

In terms of flow responses, we have reported that disturbed flow activates protein kinase Cζ (PKCζ), which induces p53 SUMOylation and increases endothelial apoptosis ([@b28-molcell-37-6-435]). In contrast, others and we have reported that laminar flow activates extracellular signal-regulated kinase-5 (ERK5), which plays a key role in maintaining EC athero-protective function *via* up-regulating Krüppel-like factor 2 (KLF2) expression, which leads to eNOS expression and anti-inflammatory effects ([@b55-molcell-37-6-435]; [@b57-molcell-37-6-435]). Unlike other ERK family kinases, ERK5 is not only a kinase but also a co-activator, and steady laminar flow increases PPARδ and MEF2 transcriptional activity *via* its upregulation of transcriptional activity ([@b1-molcell-37-6-435]; [@b53-molcell-37-6-435]). We found that disturbed flow increased ERK5 SUMOylation and inhibited its transcriptional activity, which down-regulated eNOS and KLF2 expression, leading to EC dysfunction and accelerating atherosclerotic plaque formation ([@b29-molcell-37-6-435]).

Sentrin/SUMO-specific protease 2 (SENP2) is a de-SUMOylation enzyme that is important for both processing new SUMO proteins for conjugation as well as deconjugating SUMO from SUMOylated proteins ([@b8-molcell-37-6-435]; [@b51-molcell-37-6-435]; [@b56-molcell-37-6-435]). Although humans have six isoforms (SENP1--3 and 5--7), SENP2 specifically regulates p53 through Mdm2 de-SUMOylation, leading to apoptosis ([@b10-molcell-37-6-435]; [@b32-molcell-37-6-435]). Recently, we found that reduced SENP2 expression in *Senp2*^+/−^ mice increased SUMOylation of endothelial p53 and ERK5 in ECs ([Fig. 2](#f2-molcell-37-6-435){ref-type="fig"}), hence increasing EC dysfunction and inflammation ([@b29-molcell-37-6-435]). We then generated a double-knockout *Senp2*^+/−^/*Ldlr*^−/−^ mouse model and determined the extent of plaque formation by high cholesterol diet. After 16 weeks on the diet, the lesion area in both aortic arch and descending aorta was significantly larger in *Senp2*^+/−^/*Ldlr*^−/−^ than *Senp2*^+/+^/*Ldlr*^−/−^ mice. The lesion size in the lesser curvature where blood flow is disturbed was significantly larger in *Senp2*^+/−^/*Ldlr*^−/−^ mice, suggesting a pro-atherogenic effect of disturbed flow-induced SUMOylation of proteins including ERK5 and p53. Next to support this idea, we investigated whether disturbed flow-induced EC inflammation and apoptosis *via* ERK5 and p53 SUMOylation and found that overexpression of ERK5 and p53 SUMOylation site mutants significantly reduced disturbed flow-induced EC inflammation and apoptosis, respectively ([@b29-molcell-37-6-435]). Taken together, these data strongly support a key role of SUMOylation under disturbed (athero-prone) flow and contribution of SENP2 in vascular pathology. We found that SENP2 expression was not affected by different (i.e. laminar vs disturbed) flow patterns ([@b29-molcell-37-6-435]). At present, it is not known how SENP2 is differentially regulated by the two flow types, and this mechanism awaits further investigation.

CONCLUSION
==========

Although differential endothelial responses to steady laminar flow (athero-protective) and disturbed flow (athero-prone flow) have been well established and extensive studies have been done to determine the molecular mechanism of flow-initiated mecahnotrasduction, how these two types of flow revoke different responses in ECs remains largely unclear. PECAM-1 plays a key role as a sensor to initiate mechanotransduction and subsequent signaling, which is now well established. However, PECAM-1 alone cannot answer our question how laminar and disturbed flow induces different responses in ECs because both laminar and disturbed flow activate PECAM-1 signaling. PECAM-1/VE-cadherin/VEGFR2 signaling may be critical for increased EC inflammation under disturbed flow, but not under steady laminar flow. It is now important to determine the different mechanotransduction events between these two different types of flow such as SUMOylation. We should use both "top (mechanosensor) to bottom (signaling and its functional readout)" and "bottom to top" approaches to get the clear image of flow-mediated signal transduction and mechanotransduction mechanisms.
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![En Face immunohistochemistry. The greater curvature of the aortic arch indicated by the blue circle is exposed to steady laminar flow and is protected from atherosclerosis. Regions of curvature indicated by the red circle and side branches indicated by numbers (1, 2, and 3) are exposed to disturbed flow and are athero-prone areas. The aorta was prepared from a 7 weeks old C57BL/6 wild type mouse. En face endothelial cells stained by anti-VE-cadherin show the general cell morphology in the steady laminar flow (blue square) and disturbed flow (red square) areas. Scale bars, 20 μm.](molcell-37-6-435f1){#f1-molcell-37-6-435}

![Disturbed flow induces EC dysfunction *via* p53 and ERK5 SUMOylation. Disturbed flow down-regulates SENP2 activity, which then cause EC apoptosis *via* p53 SUMOylation and subsequent p53-Bcl2 binding. On the other hand, steady laminar flow, through activation of ERK5, increases activity of MEF2/KLF2/eNOS, which are responsible for inducting anti-inflammatory responses. Disturbed flow-induced down-regulation of SENP2 triggers ERK5 SUMOylation and inhibits its transcriptional activity. S-flow, steady laminar flow; D-flow, disturbed flow; SUMO, small ubiquitin-like modifier.](molcell-37-6-435f2){#f2-molcell-37-6-435}
